Related Experiment Video

Updated: Jul 29, 2026

Intra-Arterial Delivery of Neural Stem Cells to the Rat and Mouse Brain: Application to Cerebral Ischemia
14:53

Intra-Arterial Delivery of Neural Stem Cells to the Rat and Mouse Brain: Application to Cerebral Ischemia

Published on: June 26, 2020

9.9K

[American Academy of Neurology, Philadelphia, 26 April-3 May, 2014]

F Durif1, I Sibon1, B de Toffol1

  • 1Hôpital de la Salpêtrière, bâtiment Babinski, consultation de pathologie neuro-musculaire, 47, boulevard de l'Hôpital, 75651 Paris cedex 13, France.

Revue Neurologique
|June 2, 2014
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Author Spotlight: A Novel Approach to Cerebral Ischemia Modeling – Enhancing Reperfusion and Simplifying Procedure
04:18

Author Spotlight: A Novel Approach to Cerebral Ischemia Modeling – Enhancing Reperfusion and Simplifying Procedure

Published on: May 31, 2024

2.3K
Visualizing the Gatekeeper: Evan's Blue Dye-Based Assessment of Blood-Brain Barrier Permeability in Adult Zebrafish
06:49

Visualizing the Gatekeeper: Evan's Blue Dye-Based Assessment of Blood-Brain Barrier Permeability in Adult Zebrafish

Published on: September 30, 2025

1.1K

Related Experiment Videos

Last Updated: Jul 29, 2026

Intra-Arterial Delivery of Neural Stem Cells to the Rat and Mouse Brain: Application to Cerebral Ischemia
14:53

Intra-Arterial Delivery of Neural Stem Cells to the Rat and Mouse Brain: Application to Cerebral Ischemia

Published on: June 26, 2020

9.9K
Author Spotlight: A Novel Approach to Cerebral Ischemia Modeling – Enhancing Reperfusion and Simplifying Procedure
04:18

Author Spotlight: A Novel Approach to Cerebral Ischemia Modeling – Enhancing Reperfusion and Simplifying Procedure

Published on: May 31, 2024

2.3K
Visualizing the Gatekeeper: Evan's Blue Dye-Based Assessment of Blood-Brain Barrier Permeability in Adult Zebrafish
06:49

Visualizing the Gatekeeper: Evan's Blue Dye-Based Assessment of Blood-Brain Barrier Permeability in Adult Zebrafish

Published on: September 30, 2025

1.1K

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

Articles linked to this work by shared authors, journal, and citation graph.

Geographic disparities in MRI features of ischemic stroke and small vessel disease: A comparative study between French Guiana and mainland France. Findings from the BECATOUR multicenter registry.

Revue neurologique·2026

Continuous subcutaneous perfusion of apomorphine in Parkinson's disease: Towards monotherapy?

Revue neurologique·2026

Retrospective, descriptive study of acute myelitis in French Guyana.

Revue neurologique·2025

The pattern of cortical thickness associated with executive dysfunction in MCI and SCC: The MEMENTO cohort.

Revue neurologique·2024

Epilepsy and psychosis.

Revue neurologique·2024

Medical demography at stroke centers: Current situation in France.

Revue neurologique·2023

Why did residents choose neurology? Motivational profile and influence of demographic and career factors.

Revue neurologique·2026

Tremor or myoclonus? A practical clinical approach to distinguishing two common hyperkinetic movement disorders.

Revue neurologique·2026

The good, the bad, and the ugly: A three-circuit model of Parkinson's tremor.

Revue neurologique·2026

The eyes and Parkinsonian syndromes.

Revue neurologique·2026

Autosomal recessive cerebellar ataxia: What have we learnt in the last 30 years?

Revue neurologique·2026

Trends and regional disparities in triptan dispensing in France between 2014 and 2025: A nationwide open-data study.

Revue neurologique·2026

Clinical and resting-state EEG changes following neurofeedback in adult refugees with persistent trauma-related symptoms: a transdiagnostic pre-post observational study.

Frontiers in psychiatry·2026

Psychedelics and Reward Processing: Before and After the 1970 Controlled Substances Act.

Psychedelic medicine (New Rochelle, N.Y.)·2026

A biopsychosocial perspective on obesity and eating disorders: A narrative overview and exploratory study of ghrelin, LEAP2, trait impulsivity, and eating psychopathology.

Reviews in endocrine & metabolic disorders·2026

Increased Serum TNF-α Levels Are Associated With Generalized Anxiety Disorder: A Case-Control Study.

Health science reports·2026

Subanesthetic ketamine modulates region-specific neural and endocrine responses to acute stress in rats.

Neuropharmacology·2026

Hunger recruits a parallel circuit encoding alcohol reward.

Current biology : CB·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us